These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 1602138)
21. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen. Phillips JH; Lanier LL J Immunol; 1986 Mar; 136(5):1579-85. PubMed ID: 2419407 [TBL] [Abstract][Full Text] [Related]
22. Opposing roles for caspase and calpain death proteases in L-glutamate-induced oxidative neurotoxicity. Elphick LM; Hawat M; Toms NJ; Meinander A; Mikhailov A; Eriksson JE; Kass GE Toxicol Appl Pharmacol; 2008 Oct; 232(2):258-67. PubMed ID: 18687350 [TBL] [Abstract][Full Text] [Related]
23. DNA fragmentation induced by cytotoxic T lymphocytes can result in target cell death. Helgason CD; Shi L; Greenberg AH; Shi Y; Bromley P; Cotter TG; Green DR; Bleackley RC Exp Cell Res; 1993 Jun; 206(2):302-10. PubMed ID: 8500550 [TBL] [Abstract][Full Text] [Related]
24. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure. Hiserodt JC J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707 [TBL] [Abstract][Full Text] [Related]
25. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL. Lancki DW; Kaper BP; Fitch FW J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047 [TBL] [Abstract][Full Text] [Related]
26. Pretreatment of murine donor grafts with L-leucyl-L-leucine methyl ester: elimination of graft-versus-host disease without detrimental effects on engraftment. Blazar BR; Thiele DL; Vallera DA Blood; 1990 Feb; 75(3):798-805. PubMed ID: 1967541 [TBL] [Abstract][Full Text] [Related]
27. The effect of L-leucine methyl ester on the phagocytosis and amino acid incorporation of murine peritoneal cells. Antoni F; Csuka I; Hrabák A; Temesi A; Szende B; Lapis K Acta Biochim Biophys Hung; 1989; 24(4):299-311. PubMed ID: 2487008 [TBL] [Abstract][Full Text] [Related]
28. Generalized toxicity of L-leucyl-leucine-methyl ester for lymphocyte functions. Mowat AM; Leck PA Immunology; 1990 Apr; 69(4):564-9. PubMed ID: 2335375 [TBL] [Abstract][Full Text] [Related]
29. Nonsecretory apoptotic killing by human NK cells. Vujanovic NL; Nagashima S; Herberman RB; Whiteside TL J Immunol; 1996 Aug; 157(3):1117-26. PubMed ID: 8757616 [TBL] [Abstract][Full Text] [Related]
31. Antileukemia activity of a natural killer cell line against human leukemias. Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753 [TBL] [Abstract][Full Text] [Related]
32. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. Colotta F; Peri G; Villa A; Mantovani A J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624 [TBL] [Abstract][Full Text] [Related]
33. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell. Tarkkanen J; Saksela E; Lanier LL J Immunol; 1986 Oct; 137(8):2428-33. PubMed ID: 3093576 [TBL] [Abstract][Full Text] [Related]
34. Role of intracellular free Ca(II) and Zn(II) in dexamethasone-induced apoptosis and dexamethasone resistance in human leukemic CEM cell lines. Adebodun F; Post JF J Cell Physiol; 1995 Apr; 163(1):80-6. PubMed ID: 7896902 [TBL] [Abstract][Full Text] [Related]
35. Regulation of cellular function by products of lysosomal enzyme activity: elimination of human natural killer cells by a dipeptide methyl ester generated from L-leucine methyl ester by monocytes or polymorphonuclear leukocytes. Thiele DL; Lipsky PE Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2468-72. PubMed ID: 3857595 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of caged compounds of L-leucyl-L-leucine methyl ester, an apoptosis inducer, and their cytotoxic activity. Odaka M; Furuta T; Kobayashi Y; Iwamura M Biochem Biophys Res Commun; 1995 Aug; 213(2):652-6. PubMed ID: 7646522 [TBL] [Abstract][Full Text] [Related]
38. Cell-type specificity of l-leucyl l-leucine methyl ester. Kobayashi Y; Takasaki A; Kurosaka K; Sakurai Y; Iwamura M; Watanabe N Biochem Biophys Res Commun; 2000 Jun; 272(3):687-90. PubMed ID: 10860815 [TBL] [Abstract][Full Text] [Related]
39. Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. Zychlinsky A; Zheng LM; Liu CC; Young JD J Immunol; 1991 Jan; 146(1):393-400. PubMed ID: 1984450 [TBL] [Abstract][Full Text] [Related]
40. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. Rosato RR; Almenara JA; Grant S Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]